72547-43-4 Usage
Uses
Used in Pharmaceutical Industry:
4-OXO-4-PIPERAZIN-1-YL-BUTYRIC ACID is used as a pharmaceutical intermediate for the synthesis of various drugs, contributing to the development of new therapeutic agents.
Used in Neurological Disorders Treatment:
4-OXO-4-PIPERAZIN-1-YL-BUTYRIC ACID is used as a therapeutic agent for the treatment of neurological disorders, leveraging its potential to alleviate symptoms and improve patient outcomes.
Used in Anxiety Treatment:
4-OXO-4-PIPERAZIN-1-YL-BUTYRIC ACID is used as an anxiolytic agent, helping to reduce anxiety levels and improve overall mental well-being.
Used in Antiviral Applications:
4-OXO-4-PIPERAZIN-1-YL-BUTYRIC ACID is used as an antiviral agent, exhibiting potential to inhibit viral replication and reduce the severity of viral infections.
Used in Antibacterial Applications:
4-OXO-4-PIPERAZIN-1-YL-BUTYRIC ACID is used as an antibacterial agent, demonstrating potential to combat bacterial infections and promote overall health.
Used in Cosmetic and Personal Care Industry:
4-OXO-4-PIPERAZIN-1-YL-BUTYRIC ACID is used in the production of certain cosmetic and personal care products, contributing to their efficacy and performance.
Check Digit Verification of cas no
The CAS Registry Mumber 72547-43-4 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 7,2,5,4 and 7 respectively; the second part has 2 digits, 4 and 3 respectively.
Calculate Digit Verification of CAS Registry Number 72547-43:
(7*7)+(6*2)+(5*5)+(4*4)+(3*7)+(2*4)+(1*3)=134
134 % 10 = 4
So 72547-43-4 is a valid CAS Registry Number.
72547-43-4Relevant articles and documents
Calcium-promoted hydrolysis of N-acylureas allows mild release of peptides anchored with Dpr(Phoc) linker to hydrophilic resins
Pascal, Robert,Sola, Regine
, p. 4549 - 4552 (2007/10/03)
Calcium chloride is an efficient additive for promoting the release of short peptide models anchored with Dpr(Phoc) linker to hydrophilic solid-phase synthesis supports. It was shown to induce a moderate to marked (especially for C-terminal proline peptides) increase in the rate of alkaline hydrolytic cleavage, without epimerization at the C-terminal residue, while substantially reducing the hydroxide ion concentration. Base-promoted side-reactions are therefore expected to be slowed down.